Decorative image for Follow Our Progress page banner

Follow Our Progress

Presentations RAG-01 Presentation

First-in-human study of RAG-01, a novel small activating RNA therapeutic in BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC) patients(Abstract)

By ractigen03/24/2025June 24th, 2025No Comments

PUBLICATIONS & PRESENTATIONS

03/24/25

First-in-human study of RAG-01, a novel small activating RNA therapeutic in BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC) patients(Abstract)

Event：40th Annual Congress of the European Association of Urology (EAU 2025) (Spain)

View Press Release: Ractigen’s RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025